Investigators in Switzerland are testing an application for smartphones that they hope will elucidate subtle signs of disease progression in multiple sclerosis (MS) — beyond what standard imaging and clinical biomarkers can tell them.
Medscape Medical News
Healthy life is yours
More Stories
‘Record’ rise in student nurses including 30% more men
Authors Retract Paper on HPV Vaccine and Preterm Birth
Specific assessment of the eye may help diagnose and monitor concussions